Adherence to Secondary Prophylaxis for Acute Rheumatic Fever and Rheumatic Heart Disease: A Systematic Review
- PMID: 28093988
- PMCID: PMC5452151
- DOI: 10.2174/1573403X13666170116120828
Adherence to Secondary Prophylaxis for Acute Rheumatic Fever and Rheumatic Heart Disease: A Systematic Review
Abstract
Background: Optimal delivery of regular benzathine penicillin G (BPG) injections prescribed as secondary prophylaxis for acute rheumatic fever (ARF) and rheumatic heart disease (RHD) is vital to preventing disease morbidity and cardiac sequelae in affected pediatric and young adult populations. However, poor uptake of secondary prophylaxis remains a significant challenge to ARF/RHD control programs.
Objective: In order to facilitate better understanding of this challenge and thereby identify means to improve service delivery, this systematic literature review explored rates of adherence and factors associated with adherence to secondary prophylaxis for ARF and RHD worldwide.
Methods: MEDLINE was searched for relevant primary studies published in the English language from 1994-2014, and a search of reference lists of eligible articles was performed. The methodological quality of included studies was evaluated using a modified assessment tool.
Results: Twenty studies were included in the review. There was a range of adherence to varying regimens of secondary prophylaxis reported globally, and a number of patient demographic, clinical, socio-cultural and health care service delivery factors associated with adherence to secondary prophylaxis were identified.
Conclusion: Insights into factors associated with lower and higher adherence to secondary prophylaxis may be utilized to facilitate improved delivery of secondary prophylaxis for ARF and RHD. Strategies may include ensuring an effective active recall system, providing holistic care, involving community health workers and delivering ARF/RHD health education.
Keywords: Acute rheumatic fever; adherence; benzathine benzylpenicillin; benzathine penicillin; compliance; penicillin G benzathine; rheumatic heart disease; secondary prophylaxis..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.
References
-
- Marijon E., Mirabel M., Celermajer D.S., Jouven X. Rheumatic heart disease. Lancet. 2012;379(9819):953–964. - PubMed
-
- Carapetis J.R., Steer A.C., Mulholland E.K., Weber M. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 2005;5(11):685–694. - PubMed
-
- Steer A.C., Carapetis J.R., Nolan T.M., Shann F. Systematic review of rheumatic heart disease prevalence in children in developing countries: the role of environmental factors. J. Paediatr. Child Health. 2002;38(3):229–234. - PubMed
-
- World Health Organisation . Rheumatic fever and rheumatic heart disease: report of a WHO expert consultation. Geneva: 2004.
-
- Beggs S., Peterson G., Tompson A. Antibiotic use for the prevention and treatment of rheumatic fever and rheumatic heart disease in children.; 2008.
LinkOut - more resources
Full Text Sources
Other Literature Sources
